Скачать или смотреть Workshop on Good Practices in Production as per Revised Schedule M of Drugs and Cosmetic Rules

CDSCO had taken initiation to impart training to Manufacturers and Regulators across India to provide insights and to disseminate about the new provisions in the revised Schedule M.
CDSCO had also taken initiative to strengthen the infrastructure of State and Central Government and also the Laboratory facilities.
Based on the training importance and under the Dynamic leadership of Dr. Rajeev Singh Raghuvanshi ji, Drugs Controller General (India) Training cell was created at CDSCO(HQ), New Delhi and it is headed by Dr. S. Eswara Reddy ji, Joint Drugs Controller of India. The team of the training cell had taken initiation and more efforts to move across the country (East, West, North & South) and imparted training with regard to the revised Schedule M in coordination with the State Licensing Authorities and the Indian Drug Manufacturers Association.
Inaugural of Workshop
As Chief Guest and Guests of Honour Consent proceeded for inaugural by given brief note on workshop and invited Guest of Honour presented for workshop that is Respected Sri Daara B Patel, Secretary General, IDMA, Smt K Bhuvaneswari, Assistant Drugs Controller (India) and Sri MVSSV Vara Prasad, Director (I/C) on to the Dias and later all dignitaries on the Dias light the lamp for starting of workshop and workshop started after prayer by drugs inspectors of Visakhapatnam Smt V Abhi Priya, Smt N Kalyani and Smt K Kalyani. List of Introductory Note by Facilitator Sri S Vijaya Kumar.
Opening address by S Vijaya Kumar
At this juncture, remind you of workshop conducted on 04-11-2023 at Visakhapatnam on draft rules of revision of Schedule M and now REVISIED SCHEDULE M started in force from 01-01-2025 and now we are conducting GOOD PRACTICES IN PRODUCTION as per Revised SCHEDULE M
Further it is the right time to remind GIST of key note address of Dr ESWAR REDDY delivered in earlier workshop that is
“
The objective of workshop is to disseminate critical information regarging the Revised Schedule M requirements proposed in alignment with the WHO standards and to emphasize on the importance of adhering to the revised standards to ensure highest quality and safet in drug manufacguring.”
now REVISIED SCHEDULE M started in force from 01-01-2025 to all mlanufacturers .Furthe on the representations of Small and Medium Scale Manufacturers,the government of India issued draft of Revisied Schedule M extension .As per the said notification,the smal and medium scale manufacutrers with turnover of less than 250 crores may seek exemption of the timeline for implementation and for that purpose shall make an application to the central licensing authority in FORM A within a period of 3 months from the dated of publication of said notification that is from the date of 28-12-2024 along with the plan of upgradation .For such manufacturers the timeline for implementation shall be extended till 31-12-2025.

and now we are conducting GOOD PRACTICES IN PRODUCTION as per Revised SCHEDULE M for effective implementation of SCHEDULE M